is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Rosetta Genomics Names Brian Markison Board Chairman
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account